跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
F2-4
首页
药物
F2-4
F2-4
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
F2 protein based indirect ELISA kit for detection of fowl adenovirus serotype 4 antibody
申请人: UNIV YANGZHOU
优先权: 2017
CN
F2 part deletion type recombinant serum 4 type fowl adenovirus and preparation method thereof
申请人: UNIV YANGZHOU
优先权: 2021
CN
LAYERING METHOD FOR DYEING HAIR
申请人: HENKEL AG & CO KGAA
优先权: 2024
WO
Recombinant serum 4 type fowl adenovirus with green fluorescent protein replacing Fiber-2 and preparation method of recombinant serum 4 type fowl adenovirus
申请人: UNIV YANGZHOU
优先权: 2021
CN
一种订书肽及其应用
申请人: 潍坊医学院
优先权: 2023
CN
Chalcone compound containing triazole and application thereof
申请人: UNIV HEBEI NORMAL
优先权: 2021
CN
MODIFIED PEPTIDE DERIVED FROM URECHIS UNICINCTUS IN PREPARATION OF DRUG FOR TREATING ALCOHOLIC LIVER DISEASE
申请人: BEIJING INST PETROCHEM TECH
优先权: 2024
CN
US
2 件公开
NEW PROCESS FOR THE SYNTHESIS OF 5-FLUORO-3- (DIFUOROMETHYL) -5-FLUORO-1-METHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID DERIVATIVES AND THE FREE ACID THEREOF
申请人: FUJIAN YONGJING TECH CO LTD
优先权: 2021
EP
US
WO
3 件公开
药物
反馈